KUCHARCHUK ANDREW ALBERT
SEC insider (Form 3/4/5 filer). CIK 0001654127. Chief Financial Officer at RRE Ventures Acquisition Corp. (RREV) and 3 other issuers. 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 7, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies KUCHARCHUK ANDREW ALBERT has filed insider reports for
- RRE Ventures Acquisition Corp. (RREV): Officer, Chief Financial Officer
- CERO THERAPEUTICS HOLDINGS, INC. (CERO): Officer, Chief Financial Officer
- Range Capital Acquisition Corp II (RNGTU): Officer, Chief Financial Officer
- WINDTREE THERAPEUTICS INC /DE/ (WINT): Director
KUCHARCHUK ANDREW ALBERT
CIK: 0001654127
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 7, 2026CERO
CERO THERAPEUTICS HOLDINGS, INC.
AwardDirectStock Option (Right to Buy)
1.2M shares- - May 30, 2025CERO
CERO THERAPEUTICS HOLDINGS, INC.
AwardDirectStock Option (Right to Buy)
152.5K shares- - Oct 1, 2024CERO
CERO THERAPEUTICS HOLDINGS, INC.
AwardDirectStock Option (Right to Buy)
500K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 7, 2026 |  CERO CERO THERAPEUTICS HOLDINGS, INC. | Award Stock Option (Right to Buy) | 1,162,099 | - | - | Direct |
| May 30, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award Stock Option (Right to Buy) | 152,500 | - | - | Direct |
| Oct 1, 2024 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award Stock Option (Right to Buy) | 500,000 | - | - | Direct |
1-3 of 3 transactions